Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
|
|
Prime Medicine, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2023 |
4
| Cahill Thomas (Director) has filed a Form 4 on Prime Medicine, Inc.|
Txns:
| Granted 39,062 options to buy
@ $14.83, valued at
$579.3k
|
|
| 06/16/2023 |
4
| Schenkein David P (Director) has filed a Form 4 on Prime Medicine, Inc.|
Txns:
| Granted 39,062 options to buy
@ $14.83, valued at
$579.3k
|
|
| 06/16/2023 |
4
| Foster-Cheek Kaye I (Director) has filed a Form 4 on Prime Medicine, Inc.|
Txns:
| Granted 39,062 options to buy
@ $14.83, valued at
$579.3k
|
|
| 06/16/2023 |
4
| NELSEN ROBERT (10% Owner) has filed a Form 4 on Prime Medicine, Inc.|
Txns:
| Granted 39,062 options to buy
@ $14.83, valued at
$579.3k
|
|
| 06/16/2023 |
4
| Kelly Michael Aaron (Director) has filed a Form 4 on Prime Medicine, Inc.|
Txns:
| Granted 39,062 options to buy
@ $14.83, valued at
$579.3k
|
|
| 06/16/2023 |
4
| Chung Wendy (Director) has filed a Form 4 on Prime Medicine, Inc.|
Txns:
| Granted 39,062 options to buy
@ $14.83, valued at
$579.3k
|
|
| 06/09/2023 |
4
| GV 2019 GP, L.L.C. (10% Owner) has filed a Form 4 on Prime Medicine, Inc.|
Txns:
| Disposed of 15,000 shares
@ $0
Sold 15,000 shares
@ $16.9247, valued at
$253.9k
Disposed of 5,000 shares
@ $0
Sold 5,000 shares
@ $15.7373, valued at
$78.7k
|
|
| 06/07/2023 |
4
| GV 2019 GP, L.L.C. (10% Owner) has filed a Form 4 on Prime Medicine, Inc.|
Txns:
| Disposed of 22,434 shares
@ $0
Sold 22,434 shares
@ $16.6984, valued at
$374.6k
Disposed of 29,975 shares
@ $0
Sold 29,975 shares
@ $17.0197, valued at
$510.2k
|
|
| 05/31/2023 |
4
| GV 2019 GP, L.L.C. (10% Owner) has filed a Form 4 on Prime Medicine, Inc.|
Txns:
| Disposed of 12,602 shares
@ $0
Sold 12,602 shares
@ $13.6965, valued at
$172.6k
Disposed of 16,805 shares
@ $0
Sold 16,805 shares
@ $13.7007, valued at
$230.2k
|
|
| 05/26/2023 |
4
| GV 2019 GP, L.L.C. (10% Owner) has filed a Form 4 on Prime Medicine, Inc.|
Txns:
| Disposed of 7,900 shares
@ $0
Sold 7,900 shares
@ $13.6608, valued at
$107.9k
Disposed of 23,161 shares
@ $0
Sold 23,161 shares
@ $13.3834, valued at
$310k
|
|
| 05/24/2023 |
4
| GV 2019 GP, L.L.C. (10% Owner) has filed a Form 4 on Prime Medicine, Inc.|
Txns:
| Disposed of 87,922 shares
@ $0
Sold 87,922 shares
@ $14.1272, valued at
$1.2M
Disposed of 43,939 shares
@ $0
Sold 43,939 shares
@ $14.7397, valued at
$647.6k
|
|
| 05/18/2023 |
4
| GV 2019 GP, L.L.C. (10% Owner) has filed a Form 4 on Prime Medicine, Inc.|
Txns:
| Sold 50,649 shares
@ $12.5901, valued at
$637.7k
Sold 15,000 shares
@ $12.7733, valued at
$191.6k
|
|
| 05/16/2023 |
4
| GV 2019 GP, L.L.C. (10% Owner) has filed a Form 4 on Prime Medicine, Inc.|
Txns:
| Sold 27,290 shares
@ $12.7234, valued at
$347.2k
Sold 157,952 shares
@ $12.7386, valued at
$2M
|
|
| 05/12/2023 |
4
| Marrazzo Jeffrey D (Director) has filed a Form 4 on Prime Medicine, Inc.|
Txns:
| Granted 92,000 options to buy
@ $14.04, valued at
$1.3M
|
|
| 05/12/2023 |
4
| GV 2019 GP, L.L.C. (10% Owner) has filed a Form 4 on Prime Medicine, Inc.|
Txns:
| Sold 87,397 shares
@ $14.0257, valued at
$1.2M
Sold 21,819 shares
@ $12.9815, valued at
$283.2k
Sold 4,807 shares
@ $13.7903, valued at
$66.3k
|
|
| 05/10/2023 |
4
| GV 2019 GP, L.L.C. (10% Owner) has filed a Form 4 on Prime Medicine, Inc.|
Txns:
| Sold 100,772 shares
@ $14.1282, valued at
$1.4M
Sold 321,238 shares
@ $14.0787, valued at
$4.5M
|
|
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2023 |
4
| Goldwasser Meredith (SVP, Strategy & Corporate Ops.) has filed a Form 4 on Prime Medicine, Inc.|
Txns:
| Granted 90,498 options to buy
@ $12.3, valued at
$1.1M
|
|
| 04/04/2023 |
4
| Duffield Jeremy (Chief Scientific Officer) has filed a Form 4 on Prime Medicine, Inc.|
Txns:
| Granted 180,995 options to buy
@ $12.3, valued at
$2.2M
|
|
| 04/04/2023 |
4
| Brudnick Richard (Chief Business Officer) has filed a Form 4 on Prime Medicine, Inc.|
Txns:
| Granted 135,747 options to buy
@ $12.3, valued at
$1.7M
|
|
| 04/04/2023 |
4
| Gottesdiener Keith Michael (See Remarks) has filed a Form 4 on Prime Medicine, Inc.|
Txns:
| Granted 497,738 options to buy
@ $12.3, valued at
$6.1M
|
|
| 04/04/2023 |
4
| LEE ANN L. (Chief Technical Officer) has filed a Form 4 on Prime Medicine, Inc.|
Txns:
| Granted 180,995 options to buy
@ $12.3, valued at
$2.2M
|
|
| 04/04/2023 |
4
| Alenson Carman (See Remarks) has filed a Form 4 on Prime Medicine, Inc.|
Txns:
| Granted 90,498 options to buy
@ $12.3, valued at
$1.1M
|
|
| 10/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|